Jessica Kelly
Jessica Kelly is a Senior Management Associate at ReCode Therapeutics, where she supports the CEO and SVP of Corporate Communications at one of biotech's most closely watched clinical-stage companies. With a career built in life sciences executive operations - spanning Halozyme Therapeutics and Alector before landing at ReCode - she is the connective tissue behind leadership teams racing to deliver the first nonviral mRNA therapies for cystic fibrosis and primary ciliary dyskinesia. Based in Pacifica, California, Kelly brings deep experience in C-suite operations, board logistics, and cross-functional executive coordination to a company whose SORT lipid nanoparticle platform was named by Nature as one of the seven technologies to watch in 2022.
senior-management-associaterecode-therapeuticsbiotechexecutive-supportceo-officegenetic-medicines